Loading…
USANA Health Sciences, Inc. is projected to rise to $27.32 by 2027, a +24% move from its current price of $21.98. USNA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $21.49 | $22.00 | $22.52 | +0.09% |
| Jul 14 | $21.31 | $22.02 | $22.75 | +0.18% |
| Jul 15 | $21.17 | $22.04 | $22.94 | +0.27% |
| Jul 16 | $21.06 | $22.06 | $23.11 | +0.35% |
| Jul 17 | $20.96 | $22.08 | $23.26 | +0.44% |
| Jul 18 | $20.87 | $22.10 | $23.39 | +0.53% |
| Jul 19 | $20.80 | $22.12 | $23.52 | +0.62% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.80 | $22.12 | $23.52 | +0.62% |
| Week 2 | $20.40 | $22.25 | $24.28 | +1.25% |
| Week 3 | $20.13 | $22.39 | $24.91 | +1.87% |
| Week 4 | $19.92 | $22.53 | $25.48 | +2.51% |
| Week 5 | $19.76 | $22.67 | $26.01 | +3.14% |
| Week 6 | $19.62 | $22.81 | $26.52 | +3.78% |
| Week 7 | $19.51 | $22.95 | $27.01 | +4.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
It operates in two segments, Core nutritional and Hiya Direct-To-Consumer, and offers a range of products including USANA nutritional optimizers, Essentials/CellSentials for children, and food products such as meal replacement shakes and snack bars for weight management, digestive health, and energy. It also offers Celavive, a skincare regimen, and materials and online tools for associates to build business and marketing of products.
The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
USANA Health Sciences is categorized as a Consumer Defensive stock.
Current price: $22.38. The stock is positioned with a market price around the low-to-mid $20s, reflecting a recent value level for the business.
Market cap: $413.2M, with a rank of 3223. These figures place USANA as a smaller-cap, defensive-oriented consumer health company within its market space.
Forecasts show an upward price trajectory over the long term, transitioning from a neutral near-term stance in 2026 to bullish sentiment in later years, with the average price rising from $22.38 in 2026 to substantially higher levels by 2050 (average $157.23; max $265.61).
A major floor 28.6% below — a decisive break under it would weaken the trend.
The nearest floor, 20.6% below — buyers have tended to step in here.
Price is pressing into resistance (1.8% away) — a breakout level to watch.
A major ceiling 16.1% above — clearing it would confirm fresh momentum.
Key USNA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of USNA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.87 | Buy | $21.79 | Buy |
| MA 10 | $21.56 | Buy | $21.40 | Buy |
| MA 20 | $20.44 | Buy | $20.68 | Buy |
| MA 50 | $19.25 | Buy | $19.74 | Buy |
| MA 100 | $18.97 | Buy | $19.69 | Buy |
| MA 200 | $20.13 | Buy | $21.33 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.64 | Neutral |
| Stoch RSI (14) | 57.66 | Neutral |
| CCI (20) | 91.45 | Neutral |
| Williams %R (14) | -11.49 | Info |
| MACD (12,26,9) | 0.14 | Buy |
| ROC (12) | 14.48 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 88.51 | Sell |
| TRIX (15) | 0.54 | Buy |
| Awesome (5,34) | 2.24 | Buy |
| Ultimate (7,14,28) | 63.97 | Neutral |
| Momentum (10) | 2.30 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 21.93 | Buy |
| ADX (14) | 22.26 | Buy |
| ATR (14) | 0.46 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 is 70, indicating momentum approaching overbought territory but not yet extreme. The stock trades above the SMA50 of $19.11 and the SMA200 of $20.26, suggesting a positive short-term price bias within a broad range.
The near-term support is listed at $17.46 and resistance at $22.38, with a 30-day trading range of $19.49 to $25.70. There is notable upside potential if the price can press through the $22.38 resistance level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.90 | $21.98 | $30.21 | 0% | Neutral | |
| $22.05 | $27.32 | $35.62 | +24% | Bullish | |
| $22.58 | $28.63 | $38.55 | +30% | Bullish | |
| $25.35 | $32.78 | $45.26 | +49% | Bullish | |
| $25.58 | $33.65 | $47.46 | +53% | Bullish | |
| $26.12 | $34.88 | $50.13 | +59% | Bullish | |
| $30.89 | $41.84 | $61.15 | +90% | Bullish | |
| $35.67 | $48.98 | $72.67 | +123% | Bullish | |
| $39.05 | $54.30 | $81.71 | +147% | Bullish | |
| $40.44 | $56.92 | $86.78 | +159% | Bullish | |
| $56.75 | $84.35 | $135.85 | +284% | Bullish | |
| $99.12 | $161.53 | $282.02 | +635% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $16.90 | $21.98 | $26.18 | +0.00% |
| August 2026 | $19.35 | $22.75 | $27.40 | +3.51% |
| September 2026 | $20.15 | $23.83 | $28.96 | +4.72% |
| October 2026 | $20.24 | $24.05 | $29.47 | +0.95% |
| November 2026 | $19.99 | $23.87 | $29.45 | -0.77% |
| December 2026 | $20.31 | $24.34 | $30.21 | +1.97% |
Click any year to see its month-by-month USNA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect USNA to range from $16.90 to $30.21 through 2026. The $21.98 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The USNA price prediction for 2027 points to an average of $27.32 (low $22.05, high $35.62) — a potential gain of +24% on today's $21.98. Buyers look set to stay in control over this stretch.
In 2028, USNA is projected to trade between $22.58 and $38.55, averaging $28.63 — a potential gain of +30% from today's $21.98. That is up +5% on the projected 2027 average. Momentum favours further upside here.
USANA Health Sciences, Inc.'s 2029 outlook centres on $32.78, within a $25.35 to $45.26 range. That is up +14% on the projected 2028 average. That marks a +49% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, USNA could reach as high as $47.46, with a base case around $33.65 and support toward $25.58 — roughly +53% from $21.98. Momentum favours further upside here.
Expect USNA to range from $26.12 to $50.13 through 2031. The $34.88 average target implies a +59% move from current prices. That is up +4% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The USNA price prediction for 2032 points to an average of $41.84 (low $30.89, high $61.15) — a potential gain of +90% on today's $21.98. Momentum favours further upside here.
In 2033, USNA is projected to trade between $35.67 and $72.67, averaging $48.98 — a potential gain of +123% from today's $21.98. That is up +17% on the projected 2032 average. Buyers look set to stay in control over this stretch.
USANA Health Sciences, Inc.'s 2034 outlook centres on $54.30, within a $39.05 to $81.71 range. That is up +11% on the projected 2033 average. That marks a +147% change versus current levels. Momentum favours further upside here.
By 2035, USNA could reach as high as $86.78, with a base case around $56.92 and support toward $40.44 — roughly +159% from $21.98. Buyers look set to stay in control over this stretch.
Expect USNA to range from $56.75 to $135.85 through 2040. The $84.35 average target implies a +284% move from current prices. That is up +48% on the projected 2035 average. Momentum favours further upside here.
The USNA price prediction for 2050 points to an average of $161.53 (low $99.12, high $282.02) — a potential gain of +635% on today's $21.98. Buyers look set to stay in control over this stretch.
Investing $1,000 in USNA today (≈ 45.495905 USNA) could be worth
$7,348.89
+$6,348.89 (+635%) by 2050 · US Dollar
Based on the average projected USNA price of $161.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in USNAwould be worth at today's price.
$1,000 invested in USNA on Jul 10, 2025 (≈ 29.931158 USNA) would be worth
$657.89
-$342.11 (-34.2%) today · 0.66× · US Dollar
Based on a USNA entry price of $33.41 vs. today's $21.98.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.51 | $1,021.85 | +2.2% |
| 1 month ago | $19.17 | $1,146.58 | +14.7% |
| 3 months ago | $18.11 | $1,213.69 | +21.4% |
| 6 months ago | $20.6 | $1,066.99 | +6.7% |
| 1 year ago | $33.41 | $657.89 | -34.2% |
| All time (5.0y) ago | $99.72 | $220.42 | -78.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our USNA forecast.
Our base-case forecast reaches $44.00 around 2033.
Implied market cap at $44.00: $812.37M
From 2027 onward, the outlook strengthens with BULLISH sentiment and rising averages.
In 2027 the average price is forecast at $27.60, with a 23.3% ROI attached to that year's projection. The 2028 forecast is $28.94 (ROI 29.3%), and 2029 is $33.06 (ROI 47.7%), building toward 2030 at an average of $33.73 (ROI 50.7%).
The path continues with 2031 at $34.98 (ROI 56.3%), 2032 at $41.86 (ROI 87%), 2033 at $48.36 (ROI 116.1%), 2034 at $53.49 (ROI 139), and 2035 at $56.40 (ROI 152).
By 2040, the average price is forecast to be $82.53 (ROI 268.8%), and by 2050 the average is $157.23 (ROI 602.5%), with the max reaching $265.61 in that year. These figures denote an accelerating long-term upside, while underscoring that forecasts are estimates, not guarantees, and can be affected by market conditions.
Tap a question to reveal the answer.
2030 avg $33.73, min $26.00, max $46.77; ROI 50.7%, sentiment BULLISH.
Forecasts show a bullish sentiment from 2027 onward, with rising averages (e.g., 2027 avg $27.60; 2030 avg $33.73; 2050 avg $157.23) and ROI peaking at 602.5% in 2050, though 2026 is neutral.
Yes. The 2050 forecast lists a min of $100.38 and an average of $157.23, with a max of $265.61.
Current price: $22.38. Market cap: $413.2M.
Thirty-day range: low $19.49, high $25.70.
USANA Health Sciences, Inc. Community Discussion
0Share your USANA Health Sciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.